Bayer

Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2021, the Group employed around 100,000 people and had sales of 44.1 billion euros. R&D expenses before special items amounted to 5.3 billion euros. For more information, go to www.bayer.com.

Please join Bayer Symposia!
Don’t miss today’s and tomorrow’s Bayer Lunch symposia with our leading panel of experts to understand how we can further maximize outcomes for our DME and nAMD patients!
Please join Bayer Symposia!
Don’t miss today’s and tomorrow’s Bayer Lunch symposia with our leading panel of experts to understand how we can further maximize outcomes for our DME and nAMD patients!
Join the experts @Hall 5G now!
Don’t miss today’s Bayer Lunch symposium “Aflibercept: Achieving Optimal Outcomes in Retinal Diseases” from 12:30 to 1:30pm at Hall 5G now!
Join the experts @Hall 5G now!
Don’t miss today’s Bayer Lunch symposium “Aflibercept: Achieving Optimal Outcomes in Retinal Diseases” from 12:30 to 1:30pm at Hall 5G now!
Join the experts @S421 now!
Don’t miss today’s Bayer Lunch symposium “Maximizing Patient Outcomes in nAMD, and Can We Go Further with Disease Control?” from 12:30 to 1:30pm at S421 now!
Join the experts @S421 now!
Don’t miss today’s Bayer Lunch symposium “Maximizing Patient Outcomes in nAMD, and Can We Go Further with Disease Control?” from 12:30 to 1:30pm at S421 now!